Jane Street’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $626K | Buy |
38,420
+18,820
| +96% | +$356K | ﹤0.01% | 7513 |
|
|
2025
Q4 | $413K | Buy |
+19,600
| New | +$532K | ﹤0.01% | 8129 |
|
|
2025
Q3 | – | Sell |
-7,740
| Closed | -$579K | – | 11333 |
|
|
2025
Q2 | $579K | Buy |
7,740
+2,890
| +60% | +$256K | ﹤0.01% | 6646 |
|
|
2025
Q1 | $457K | Sell |
4,850
-4,260
| -47% | -$312K | ﹤0.01% | 7044 |
|
|
2024
Q4 | $660K | Buy |
9,110
+2,110
| +30% | +$129K | ﹤0.01% | 6174 |
|
|
2024
Q3 | $409K | Buy |
+7,000
| New | +$425K | ﹤0.01% | 7533 |
|
|
2022
Q2 | – | Sell |
-12,330
| Closed | -$4.33M | – | 10343 |
|
|
2022
Q1 | $4.33M | Sell |
12,330
-10,190
| -45% | -$3.99M | ﹤0.01% | 3277 |
|
|
2021
Q4 | $5.8M | Sell |
22,520
-19,680
| -47% | -$4.53M | ﹤0.01% | 2630 |
|
|
2021
Q3 | $8.99M | Buy |
42,200
+18,590
| +79% | +$3.95M | ﹤0.01% | 1940 |
|
|
2021
Q2 | $4.56M | Buy |
23,610
+5,600
| +31% | +$1.26M | ﹤0.01% | 2816 |
|
|
2021
Q1 | $3.92M | Buy |
18,010
+9,345
| +108% | +$1.81M | ﹤0.01% | 2787 |
|
|
2020
Q4 | $2.19M | Buy |
+8,665
| New | +$3.3M | ﹤0.01% | 3326 |
|
|
2020
Q3 | – | Sell |
-95
| Closed | -$66K | – | 7570 |
|
|
2020
Q2 | $66K | Sell |
95
-185
| -66% | -$232K | ﹤0.01% | 6811 |
|
|
2020
Q1 | $788K | Sell |
280
-1,177
| -81% | -$3.36M | ﹤0.01% | 3076 |
|
|
2019
Q4 | $3.6M | Sell |
1,457
-106
| -7% | -$376K | 0.01% | 1349 |
|
|
2019
Q3 | $7.91M | Buy |
1,563
+20
| +1% | +$82.3K | 0.01% | 713 |
|
|
2019
Q2 | $5.56M | Buy |
1,543
+174
| +13% | +$733K | 0.01% | 974 |
|
|
2019
Q1 | $5.03M | Sell |
1,369
-666
| -33% | -$3.23M | 0.01% | 1145 |
|
|
2018
Q4 | $17.4M | Buy |
2,035
+166
| +9% | +$1.22M | 0.04% | 361 |
|
|
2018
Q3 | $9.12M | Sell |
1,869
-116
| -6% | -$560K | 0.02% | 665 |
|
|
2018
Q2 | $10.3M | Buy |
1,985
+1,818
| +1,089% | +$11M | 0.02% | 597 |
|
|
2018
Q1 | $1.22M | Buy |
167
+80
| +92% | +$556K | ﹤0.01% | 2413 |
|
|
2017
Q4 | $799K | Buy |
87
+75
| +625% | +$747K | ﹤0.01% | 2628 |
|
|
2017
Q3 | $112K | Sell |
12
-16
| -57% | -$193K | ﹤0.01% | 4253 |
|
|
2017
Q2 | $382K | Sell |
28
-39
| -58% | -$749K | ﹤0.01% | 3351 |
|
|
2017
Q1 | $1.41M | Sell |
67
-36
| -35% | -$890K | 0.01% | 1693 |
|
|
2016
Q4 | $3.89M | Buy |
103
+68
| +194% | +$2.62M | 0.02% | 839 |
|
|
2016
Q3 | $1.21M | Sell |
35
-93
| -73% | -$4.35M | 0.01% | 1729 |
|
|
2016
Q2 | $9.33M | Buy |
128
+1
| +0.8% | +$80.6K | 0.05% | 364 |
|
|
2016
Q1 | $13.5M | Buy |
127
+100
| +370% | +$12.8M | 0.08% | 224 |
|
|
2015
Q4 | $1.69M | Buy |
+27
| New | +$2.06M | 0.01% | 1218 |
|
Other funds holding LABD
IC
CCM
CF
GS
Jane Street's LABD Position: Q1 2026 in Review
Jane Street increased its Direxion Daily S&P Biotech Bear 3X ETF (LABD) stake by 89% in Q1 2026, buying an estimated $548K and bringing the position to 61,389 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #6491.
Jane Street first reported a position in LABD in Q2 2015 and has held it in 40 quarters since. The position peaked at $7.13M in Q3 2022. 17 funds tracked by Wall St. Rank hold LABD as of Q1 2026.
- Jane Street held 61,389 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $1M as of Q1 2026.
- Jane Street bought 28,929 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2026, an estimated $548K.
- Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #6491 holding.
- Jane Street first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2015 and has held it in 40 quarters since.
- Jane Street's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $7.13M in Q3 2022.
- 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.